ENDOPREDICT (Testing Service by AGIOMIX)

It is the only 2nd generation Breast Cancer Prognostic test. The final EPclin Risk Score is calculated combining the 12-Gene Molecular Score with clinical pathological prognostic factors (tumor size and lymph node status)